Main Article Content
Abstract
RÉSUMÉ
L’otomycose est une affection fréquente dans les zones tropicales. Au CHR de Sédhiou, une étude rétrospective (2022–2025) a retrouvé une fréquence hospitalière de 5,14 % (86 cas sur 1 673 patients). Le diagnostic, reposant uniquement sur l’otomicroscopie en l’absence de mycologie, et la fréquence des pertes de suivi ont constitué des défis majeurs. Malgré un traitement efficace dans 66,28 % des cas, la résistance et la récidive demeurent préoccupantes, soulignant la nécessité d’améliorer l’accès au diagnostic mycologique et à des options thérapeutiques adaptées en milieu rural à ressources limitées.
ABSTRACT
Otomycosis is a common disease in tropical areas. At the Sédhiou Regional Hospital, a retrospective study (2022-2025) found a hospital incidence rate of 5.14% (86 cases out of 1,673 patients). Diagnosis, based solely on otomicroscopy in the absence of mycology, and the frequency of follow-up losses were major challenges. Despite effective treatment in 66.28% of cases, resistance and recurrence remain a concern, underlining the need to improve access to mycological diagnosis and appropriate treatment options in rural areas with limited resources.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- 1. Anwar K, Gohar MS. Otomycosis: Clinical features, predisposing factors and therapeutic implications. Pak J Med Sci. 2014 May;30(3):564–567.
- 2. R Mgbe, A Umana, A Adekanye, M Offiong. Otomycosis – A therapeutic challenge in Calabar, South-South Nigeria. The Internet Journal of Third World Medicine. 2010;9(2).
- 3. Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical characteristics. Curr Med Mycol. 2017 Sep;3(3):27–30.
- 4. Agarwal P. Otomycosis in a rural community attending a tertiary hospital: Risk factors and identification of fungal and bacterial agents. J Clin Diagn Res. 2017 Jun;11(6):DC14–8.
- 5. Dieng T, Dieng Y, Sow D, Tine RC, Yatassaye F, Dia M, et al. Otomycosis at Fann Hospital, Dakar (Senegal): Prevalence and mycological study. J Mycol Mycol Sci. 2020;3(2):000129.
- 6. Agence Nationale de la Statistique et de la Démographie (ANSD). Situation Économique et Sociale de la Région de Sédhiou, édition 2020/2021 [Internet]. Dakar: ANSD; 2023 [cited 2025 Sep 10]. Disponible sur : https://www.ansd.sn/sites/default/files/2024-01/SES-Sedhiou_2020-2021.pdf
- 7. Tchiengang KJN, Tchiengang EV, Kalungwe YK, Diom ES, Diallo BK. Overview of Ear Diseases in Rural Areas of Southern Senegal. Health Res Afr. 2025 Aug 30;3(9):103–108.
- 8. Ho T, Truebec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and therapeutic implications. Otolaryngol Head Neck Surg. 2006 Nov;135(5):787–791.
- 9. Khasanov US, Khudjanov SK, Djuraev JA, Botirov AJ. Mycological and clinical studies of otomycosis: Specific aspects. Am J Med Sci Pharm Res. 2022;4(1):40–59.
- 10. Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in Iran: A review. Mycopathologia. 2015 Jun;179(5–6):415–424.
- 11. Lecanu JB, Erminy M, Faulcon P, Théoleyre B. Otomycosis. EMC-Oto-Rhino-Laryngol. 2008 Jan;3(4):1–8.
- 12. Aboulmakarim S, Tligui H, El Mrini M, Zakaria I, Handour N, Agoumi A. Otomycoses: Clinical and mycological study of 70 cases. J Med Mycol. 2010 Mar;20(1):48–52.
- 13. Diop A, Younes H, Diop PS, Diallo K, Sambou Y, Diongue K, et al. Epidemiological profile of otomycosis at Paix Hospital, Ziguinchor (Senegal). J Fungi. 2025 Mar 12;11(3):218.
- 14. Doubryn KD, N’Gattia VK, Kouadio-Yapo GC, Nigué L, Zika DK, Ouhon J. Epidemiology of otomycosis at the University Hospital Center of Yopougon (Abidjan, Côte d’Ivoire). J Med Mycol. 2014 Jun;24(2):E9–15.
- 15. Debta P, Swain SK, Lenka S, Sahu MC. Otomycosis: A comprehensive review. Indian J Forensic Med Toxicol. 2020;14(4):8429.
- 16. Ho T, Truebec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and therapeutic implications. Otolaryngol Head Neck Surg. 2006 Nov;135(5):787–791.
- 17. Ali K, Hamed MA, Hassan H, Esmail A, Sheneef A. Identification of fungal agents in otomycosis and their drug susceptibility: Our experience. Int Arch Otorhinolaryngol. 2018 Oct;22(4):400–403. doi: 10.1055/s-0038-1626702
- 18. Crisafulli F, Leone L, Romagnoli M, Liborio A, De Virgilio A, De Vincentiis M. Recurrent Aspergillus otomycosis despite prolonged systemic antifungal therapy: Resolution after topical voriconazole. Med Mycol Case Rep. 2022 Dec 28;39:23–25. doi: 10.1016/j.mmcr.2022.12.006
- 19. Tchiengang KJN, Koundoul A, Eliada VT, Diagne M, Kane Y, Issa W, Diallo BK. Knowledge, attitudes and practices of patients with ear diseases in the Sédhiou region (Senegal). Health Sci Dis. 2025;24(1):e7007. Available from: https://www.hsd-fmsb.org/index.php/hsd/article/view/7007/5310
- 20. Wee LE, Tan MG, Tan AL, Tang JZ. Recurrent Aspergillus otomycosis despite prolonged systemic antifungal therapy: Resolution after topical voriconazole. Med Mycol Case Rep. 2022 Dec 28;39:23–25. doi: 10.1016/j.mmcr.2022.12.006
References
1. Anwar K, Gohar MS. Otomycosis: Clinical features, predisposing factors and therapeutic implications. Pak J Med Sci. 2014 May;30(3):564–567.
2. R Mgbe, A Umana, A Adekanye, M Offiong. Otomycosis – A therapeutic challenge in Calabar, South-South Nigeria. The Internet Journal of Third World Medicine. 2010;9(2).
3. Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical characteristics. Curr Med Mycol. 2017 Sep;3(3):27–30.
4. Agarwal P. Otomycosis in a rural community attending a tertiary hospital: Risk factors and identification of fungal and bacterial agents. J Clin Diagn Res. 2017 Jun;11(6):DC14–8.
5. Dieng T, Dieng Y, Sow D, Tine RC, Yatassaye F, Dia M, et al. Otomycosis at Fann Hospital, Dakar (Senegal): Prevalence and mycological study. J Mycol Mycol Sci. 2020;3(2):000129.
6. Agence Nationale de la Statistique et de la Démographie (ANSD). Situation Économique et Sociale de la Région de Sédhiou, édition 2020/2021 [Internet]. Dakar: ANSD; 2023 [cited 2025 Sep 10]. Disponible sur : https://www.ansd.sn/sites/default/files/2024-01/SES-Sedhiou_2020-2021.pdf
7. Tchiengang KJN, Tchiengang EV, Kalungwe YK, Diom ES, Diallo BK. Overview of Ear Diseases in Rural Areas of Southern Senegal. Health Res Afr. 2025 Aug 30;3(9):103–108.
8. Ho T, Truebec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and therapeutic implications. Otolaryngol Head Neck Surg. 2006 Nov;135(5):787–791.
9. Khasanov US, Khudjanov SK, Djuraev JA, Botirov AJ. Mycological and clinical studies of otomycosis: Specific aspects. Am J Med Sci Pharm Res. 2022;4(1):40–59.
10. Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in Iran: A review. Mycopathologia. 2015 Jun;179(5–6):415–424.
11. Lecanu JB, Erminy M, Faulcon P, Théoleyre B. Otomycosis. EMC-Oto-Rhino-Laryngol. 2008 Jan;3(4):1–8.
12. Aboulmakarim S, Tligui H, El Mrini M, Zakaria I, Handour N, Agoumi A. Otomycoses: Clinical and mycological study of 70 cases. J Med Mycol. 2010 Mar;20(1):48–52.
13. Diop A, Younes H, Diop PS, Diallo K, Sambou Y, Diongue K, et al. Epidemiological profile of otomycosis at Paix Hospital, Ziguinchor (Senegal). J Fungi. 2025 Mar 12;11(3):218.
14. Doubryn KD, N’Gattia VK, Kouadio-Yapo GC, Nigué L, Zika DK, Ouhon J. Epidemiology of otomycosis at the University Hospital Center of Yopougon (Abidjan, Côte d’Ivoire). J Med Mycol. 2014 Jun;24(2):E9–15.
15. Debta P, Swain SK, Lenka S, Sahu MC. Otomycosis: A comprehensive review. Indian J Forensic Med Toxicol. 2020;14(4):8429.
16. Ho T, Truebec JT, Yoo D, Coker NJ. Otomycosis: Clinical features and therapeutic implications. Otolaryngol Head Neck Surg. 2006 Nov;135(5):787–791.
17. Ali K, Hamed MA, Hassan H, Esmail A, Sheneef A. Identification of fungal agents in otomycosis and their drug susceptibility: Our experience. Int Arch Otorhinolaryngol. 2018 Oct;22(4):400–403. doi: 10.1055/s-0038-1626702
18. Crisafulli F, Leone L, Romagnoli M, Liborio A, De Virgilio A, De Vincentiis M. Recurrent Aspergillus otomycosis despite prolonged systemic antifungal therapy: Resolution after topical voriconazole. Med Mycol Case Rep. 2022 Dec 28;39:23–25. doi: 10.1016/j.mmcr.2022.12.006
19. Tchiengang KJN, Koundoul A, Eliada VT, Diagne M, Kane Y, Issa W, Diallo BK. Knowledge, attitudes and practices of patients with ear diseases in the Sédhiou region (Senegal). Health Sci Dis. 2025;24(1):e7007. Available from: https://www.hsd-fmsb.org/index.php/hsd/article/view/7007/5310
20. Wee LE, Tan MG, Tan AL, Tang JZ. Recurrent Aspergillus otomycosis despite prolonged systemic antifungal therapy: Resolution after topical voriconazole. Med Mycol Case Rep. 2022 Dec 28;39:23–25. doi: 10.1016/j.mmcr.2022.12.006